LEADS BIOLABS' PD-L1/4-1BB BISPECIFIC ANTIBODY IND APPLICATION FOR COMBINATION THERAPY IN METASTATIC COLORECTAL CANCER APPROVED, FURTHER STRENGTHENING GASTROINTESTINAL ONCOLOGY FRANCHISE

Reuters · 2d ago

Please log in to view news